Form 8-K - Current report:
SEC Accession No. 0001640334-25-000732
Filing Date
2025-05-01
Accepted
2025-05-01 16:24:33
Documents
18
Period of Report
2025-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm   iXBRL 8-K 34360
2 FORM OF SUBSCRIPTION AGREEMENT artl_ex101.htm EX-10.1 62501
3 FORM OF CONVERTIBLE NOTE artl_ex102.htm EX-10.2 32816
4 FORM OF WARRANT artl_ex103.htm EX-10.3 73911
  Complete submission text file 0001640334-25-000732.txt   371803

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA artl-20250427.xsd EX-101.SCH 5874
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20250427_lab.xml EX-101.LAB 15188
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20250427_cal.xml EX-101.CAL 898
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20250427_pre.xml EX-101.PRE 9628
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20250427_def.xml EX-101.DEF 2099
20 EXTRACTED XBRL INSTANCE DOCUMENT artl_8k_htm.xml XML 4021
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 25903518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)